volume 415 issue 6872 pages 686-693

Medical need, scientific opportunity and the drive for antimalarial drugs

Robert G. Ridley 1
1
 
Medicines for Malaria Venture, Geneva, Switzerland
Publication typeJournal Article
Publication date2002-02-01
scimago Q1
wos Q1
SJR18.288
CiteScore78.1
Impact factor48.5
ISSN00280836, 14764687
PubMed ID:  11832957
Multidisciplinary
Abstract
Continued and sustainable improvements in antimalarial medicines through focused research and development are essential for the world's future ability to treat and control malaria. Unfortunately, malaria is a disease of poverty, and despite a wealth of scientific knowledge there is insufficient market incentive to generate the competitive, business-driven industrial antimalarial drug research and development that is normally needed to deliver new products. Mechanisms of partnering with industry have been established to overcome this obstacle and to open up and build on scientific opportunities for improved chemotherapy in the future.
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
Journal of Medicinal Chemistry
28 publications, 4.61%
Bioorganic and Medicinal Chemistry Letters
22 publications, 3.62%
Bioorganic and Medicinal Chemistry
19 publications, 3.13%
Journal of Organic Chemistry
15 publications, 2.47%
European Journal of Medicinal Chemistry
15 publications, 2.47%
Malaria Journal
14 publications, 2.31%
Antimicrobial Agents and Chemotherapy
11 publications, 1.81%
Journal of Ethnopharmacology
9 publications, 1.48%
Experimental Parasitology
8 publications, 1.32%
Medicinal Chemistry Research
8 publications, 1.32%
ChemMedChem
8 publications, 1.32%
Proceedings of the National Academy of Sciences of the United States of America
8 publications, 1.32%
Biochemical and Biophysical Research Communications
7 publications, 1.15%
Journal of Physical Chemistry B
7 publications, 1.15%
Parasitology Research
6 publications, 0.99%
Nature
6 publications, 0.99%
Advanced Synthesis and Catalysis
6 publications, 0.99%
Memorias do Instituto Oswaldo Cruz
6 publications, 0.99%
International Journal for Parasitology
5 publications, 0.82%
Journal of Biological Chemistry
5 publications, 0.82%
Molecular and Biochemical Parasitology
5 publications, 0.82%
Molecules
5 publications, 0.82%
Journal of Molecular Structure
5 publications, 0.82%
European Journal of Organic Chemistry
5 publications, 0.82%
Chemical Biology and Drug Design
5 publications, 0.82%
Organic and Biomolecular Chemistry
5 publications, 0.82%
Crystal Growth and Design
4 publications, 0.66%
Tetrahedron Letters
4 publications, 0.66%
Molecular Microbiology
4 publications, 0.66%
5
10
15
20
25
30

Publishers

20
40
60
80
100
120
140
160
180
200
Elsevier
187 publications, 30.81%
American Chemical Society (ACS)
77 publications, 12.69%
Springer Nature
77 publications, 12.69%
Wiley
75 publications, 12.36%
Taylor & Francis
27 publications, 4.45%
Royal Society of Chemistry (RSC)
22 publications, 3.62%
American Society for Microbiology
15 publications, 2.47%
MDPI
13 publications, 2.14%
Oxford University Press
8 publications, 1.32%
Ovid Technologies (Wolters Kluwer Health)
8 publications, 1.32%
Proceedings of the National Academy of Sciences (PNAS)
8 publications, 1.32%
Public Library of Science (PLoS)
7 publications, 1.15%
Fundacao Oswaldo Cruz
6 publications, 0.99%
Georg Thieme Verlag KG
6 publications, 0.99%
American Society for Biochemistry and Molecular Biology
4 publications, 0.66%
Bentham Science Publishers Ltd.
3 publications, 0.49%
International Union of Crystallography (IUCr)
3 publications, 0.49%
SAGE
3 publications, 0.49%
Hindawi Limited
3 publications, 0.49%
Beilstein-Institut
2 publications, 0.33%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
2 publications, 0.33%
Cambridge University Press
2 publications, 0.33%
Walter de Gruyter
2 publications, 0.33%
American Association for the Advancement of Science (AAAS)
2 publications, 0.33%
University of Chicago Press
1 publication, 0.16%
The Company of Biologists
1 publication, 0.16%
F1000 Research
1 publication, 0.16%
Mary Ann Liebert
1 publication, 0.16%
20
40
60
80
100
120
140
160
180
200
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
607
Share
Cite this
GOST |
Cite this
GOST Copy
Ridley R. G. Medical need, scientific opportunity and the drive for antimalarial drugs // Nature. 2002. Vol. 415. No. 6872. pp. 686-693.
GOST all authors (up to 50) Copy
Ridley R. G. Medical need, scientific opportunity and the drive for antimalarial drugs // Nature. 2002. Vol. 415. No. 6872. pp. 686-693.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/415686a
UR - https://doi.org/10.1038/415686a
TI - Medical need, scientific opportunity and the drive for antimalarial drugs
T2 - Nature
AU - Ridley, Robert G.
PY - 2002
DA - 2002/02/01
PB - Springer Nature
SP - 686-693
IS - 6872
VL - 415
PMID - 11832957
SN - 0028-0836
SN - 1476-4687
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2002_Ridley,
author = {Robert G. Ridley},
title = {Medical need, scientific opportunity and the drive for antimalarial drugs},
journal = {Nature},
year = {2002},
volume = {415},
publisher = {Springer Nature},
month = {feb},
url = {https://doi.org/10.1038/415686a},
number = {6872},
pages = {686--693},
doi = {10.1038/415686a}
}
MLA
Cite this
MLA Copy
Ridley, Robert G.. “Medical need, scientific opportunity and the drive for antimalarial drugs.” Nature, vol. 415, no. 6872, Feb. 2002, pp. 686-693. https://doi.org/10.1038/415686a.